NUWE

Nuwellis Inc

NUWE, USA

Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company offers Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure. Its Aquadex FlexFlow system includes a console, disposable blood circuit set, and disposable catheter. The company sells its products to hospitals and clinics through its direct salesforce in the United States; and through independent specialty distributors in Austria, Belarus, Brazil, Colombia, the Czech Republic, Germany, Greece, Hong Kong, India, Indonesia, Israel, Italy, Panama, Romania, Singapore, Slovakia, Spain, Switzerland, Thailand, the United Arab Emirates, and the United Kingdom. The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc. in April 2021. Nuwellis, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.

https://www.nuwellis.com

Stock Price

$0.00

0%

increase compared to yesterday.

Dividend

Frequency:

N/A

Rate:

N/A

Next Payout:

N/A
NUWE
stock
NUWE

Smart Money: Is Park Hotels Resorts Inc stock showing strong momentum - Analyst Downgrade & Growth Oriented Trade Recommendations baoquankhu1.vn

Read more →
NUWE
stock
NUWE

12 Health Care Stocks Moving In Monday's Intraday Session Benzinga

Read more →

Showing 2 of 10

Analyst Ratings & Sentiment

(Last Updated 2025-09-30)

Rating:

BUY

Target Price:

$11

Analyst Picks

Strong Buy

0

Buy

1

Hold

0

Sell

0

Strong Sell

0

Sentiment:

Bullish

Finn Analysis

(Last Updated 2025-09-30)

Health Score

Price to Book Ratio (P/B)

-

Very Low

0.43

Low ≤ 1

High ≥ 3

Return on Equity (ROE)

-

Low

11.98 %

Low ≤ 5%

High ≥ 25%

Return on Assets (ROA)

-

Medium

5.86 %

Low ≤ 2%

High ≥ 10%

Free Cash Flow - Revenue % (FCF)

-

Very Low

-146.37 %

Low ≤ 5%

High ≥ 15%

Debt to Equity

-

Very Low

1.04

Low ≥ 1

High ≤ 0.3

Investors

* Institutions hold a combined 0.27% of the total shares of Nuwellis Inc

1.

Geode Capital Management, LLC

(0.0904%)

since

2025/03/31

2.

Fidelity Extended Market Index

(0.0655%)

since

2025/07/31

3.

XTX Topco Ltd

(0.0468%)

since

2025/03/31

4.

Fidelity Series Total Market Index

(0.021%)

since

2025/07/31

5.

Tower Research Capital LLC

(0.0162%)

since

2025/03/31

6.

UBS Group AG

(0.0109%)

since

2025/03/31

7.

Fidelity Total Market Index

(0.0083%)

since

2025/07/31

8.

SBI Securities Co Ltd

(0.0067%)

since

2025/06/30

9.

Spartan Total Market Index Pool G

(0.0044%)

since

2025/07/31

10.

Vanguard Institutional Extnd Mkt Idx Tr

(0.0034%)

since

2025/07/31

11.

Bank of America Corp

(0.0001%)

since

2025/03/31

12.

JPMorgan Chase & Co

(0%)

since

2025/06/30

13.

Virtu Financial LLC

(0%)

since

2025/06/30

14.

TWO SIGMA SECURITIES, LLC

(0%)

since

2025/06/30

15.

Citadel Advisors Llc

(0%)

since

2025/06/30

16.

HRT FINANCIAL LLC

(0%)

since

2025/06/30

17.

NT Ext Equity Mkt Idx Fd - NL

(0%)

since

2025/06/30

* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.

Earnings History

EPS ActualEPS EstimateEPS DifferenceSurprise Percent

Upcoming Earnings Release

Date

—

EPS Estimate

—

Latest Release

Date

2025-09-30

EPS Actual

0.56

EPS Estimate

-0.23

EPS Difference

0.79

Surprise Percent

343.4783%

Investing Fit Scorecard

(Last Updated 2025-09-30)

Deep Value
Strong Deep Value(8)
Defensive
Moderately Defensive(6)
Dividend
Weak Dividend Profile(2)
Economic Moat
Some Competitive Advantage(6)
GARP
Fair GARP(3.5)
Growth
Weak Growth Prospect(2.5)
Momentum
Moderate Momentum(3.5)
Net Net
Strong Net-Net(7)
Quality
Moderate Quality(4.5)
Value
Undervalued(8)

Income Statement

(Last Updated 2025-09-30)

Revenue

$ 0

Cost Of Revenue

$ 0

Gross Profit

$ 0

Operating Expenses

$ 0

Operating Income

$ 0

Interest Expense

$ 0

Pretax Income

$ 0

Net Income

$ 0

Income Tax Expense

$ 0

EBITDA

$ 0

Total Other Income Expense Net

$ 0

Earnings Per Share

0

Dividends Per Share

0

Shares Outstanding

0

Operating Margin

0%

Trend

Balance Sheet

(Last Updated 2025-09-30)

Cash

$ 0

Short Term Investments

$ 0

Receivables

$ 0

Inventories

$ 0

Total Current Assets

$ 0

Property Plant Equipment

$ 0

Total Assets

$ 0

Payables

$ 0

Short Term Debt

$ 0

Long Term Debt

$ 0

Total Liabilities

$ 0

Equity

$ 0

Trend

Cash Flow

(Last Updated 2025-09-30)

Net Income

$ 0

Depreciation

$ 0

Change In Working Capital

$ 0

Cash From Operations

$ 0

Capital Expenditures

$ 0

Cash From Investing

$ 0

Cash From Financing

$ 0

Net Change In Cash

$ 0

Trend

Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.